Nomic is a Biotech company based in Montreal, Canada. It has raised $60M in total funding. Latest round: Series B.
Nomic funding overview
Nomic is a Biotech company based in Montreal, Canada. Nomic has raised $60M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series B announced in September 2024. The round record for Nomic runs through 2024; nothing later has been disclosed. Investors on record include Amplitude Ventures, AVANT BIO, Lux Capital, Real Ventures, SR One. 5 distinct backers are named across the disclosed rounds.
Nomic at a glance
Total raised
$60M
Latest round
Series B
Latest round date
September 2024
Industry
Biotech
Headquarters
Montreal, Canada
Notable investors
Amplitude Ventures, AVANT BIO, Lux Capital, Real Ventures, SR One
Frequently asked about Nomic funding
How much has Nomic raised?
Nomic has raised $60M in total disclosed funding across the rounds on record.
Who has invested in Nomic?
Amplitude Ventures, AVANT BIO, Lux Capital, Real Ventures, SR One are named among the investors backing Nomic.
What was the latest Nomic funding round?
The most recent disclosed round is a Series B, announced in September 2024.
Where is Nomic based?
Nomic is based in Montreal, Canada.
What sector does Nomic operate in?
Nomic is tracked under Biotech from Montreal, Canada, with $60M in disclosed funding.
When did Nomic last raise?
The last disclosed Nomic round closed in September 2024 at Series B.
Totals shown for Nomic aggregate every disclosed round on file. To see how that compares, browse the Biotech companies in Montreal and the investors behind them below.
